Logo for Avicanna Inc

Avicanna Investor Relations Material

Latest events

Logo for Avicanna Inc

Q4 2023

Avicanna
Logo for Avicanna

Q1 2024

14 May, 2024
Logo for Avicanna

Q4 2023

2 Apr, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Avicanna Inc

Access all reports
Avicanna Inc. is a Canadian international commercial-stage biopharmaceutical company focused on the development, advancement, and commercialization of evidence-based cannabinoid-based products. The company operates in the global medical and pharmaceutical market segments, leveraging its established scientific platform, including research and development (R&D) and clinical development. This platform has enabled Avicanna to launch over thirty proprietary products, along with a robust pharmaceutical pipeline aimed at addressing a range of medical conditions. Avicanna's business strategy encompasses active and commercial business pillars that include medical cannabis and wellness products, as well as a medical cannabis care portal. The company is headquartered in Toronto, Canada, and its shares are listed on the Toronto Stock Exchange.